KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Globus Medical (GMED) Shares Outstanding (Weighted Average) (2016 - 2020)

Historic Shares Outstanding (Weighted Average) for Globus Medical (GMED) over the last 10 years, with Q3 2020 value amounting to $98.5 million.

  • Globus Medical's Shares Outstanding (Weighted Average) fell 79.1% to $98.5 million in Q3 2020 from the same period last year, while for Sep 2020 it was $98.5 million, marking a year-over-year decrease of 79.1%. This contributed to the annual value of $99.1 million for FY2019, which is 129.34% up from last year.
  • Globus Medical's Shares Outstanding (Weighted Average) amounted to $98.5 million in Q3 2020, which was down 79.1% from $98.6 million recorded in Q2 2020.
  • Over the past 5 years, Globus Medical's Shares Outstanding (Weighted Average) peaked at $99.6 million during Q1 2020, and registered a low of $95.4 million during Q1 2016.
  • Over the past 5 years, Globus Medical's median Shares Outstanding (Weighted Average) value was $97.8 million (recorded in 2018), while the average stood at $97.4 million.
  • In the last 5 years, Globus Medical's Shares Outstanding (Weighted Average) soared by 194.86% in 2019 and then crashed by 79.1% in 2020.
  • Globus Medical's Shares Outstanding (Weighted Average) (Quarter) stood at $95.6 million in 2016, then rose by 0.62% to $96.2 million in 2017, then rose by 1.71% to $97.9 million in 2018, then rose by 1.29% to $99.1 million in 2019, then fell by 0.7% to $98.5 million in 2020.
  • Its Shares Outstanding (Weighted Average) was $98.5 million in Q3 2020, compared to $98.6 million in Q2 2020 and $99.6 million in Q1 2020.